Is oral anticoagulation plus antiplatelet therapy superior to oral anticoagulation alone in patients with atrial fibrillation and stable coronary artery disease?-Reference-Cited by-同舟云学术

Is oral anticoagulation plus antiplatelet therapy superior to oral anticoagulation alone in patients with atrial fibrillation and stable coronary artery disease?

Published:2022-10-15 Issue: Volume: Page:
ISSN:1383-875X
Container-title:Journal of Interventional Cardiac Electrophysiology
language:en
Short-container-title:J Interv Card Electrophysiol

Author:

Gonzalez Virginia Laura,Gonzalez Mario Daniel^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10840-022-01379-7.pdf

Reference7 articles.

1. Sonia S, Anand SS, Yusuf S. Oral anticoagulants in patients with coronary artery disease. J Am Coll Cardiol. 2003;41:62S-69S.

2. Lopes RD, Heiser G, Aronson R, Vora AN, Massaro T, Mehran R, Goodman SG, Windecker S, Darius H, Li J, Averkov O, Bahit MC, et al. for the AUGUSTUS Investigators Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation. N Engl J Med. 2019;380:1509–24.

3. Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the task force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018;39:213–60.

4. Matsumura-Nakano Y, Shizuta S, Komasa A, Morimoto T, Masuda H, Shiomi H, et al. Open-label randomized trial comparing oral anticoagulation with and without single antiplatelet therapy in patients with atrial fibrillation and stable coronary artery disease beyond one year after coronary stent implantation. Circulation. 2019;139:604–16.

5. Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Miyauchi K, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H, for the AFIRE investigators. Antithrombotic therapy for atrial fibrillation with stable coronary disease. N Eng J Med. 2019;381:1103–13.